Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children
Open Access
- 10 August 2015
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 16 (8) , 18601-18627
Abstract
Hematopoietic stem cell transplantation (HSCT) is an established therapeutic procedure for several congenital and acquired disorders, both malignant and nonmalignant. Despite the great improvements in HSCT clinical practices over the last few decades, complications, such as graft vs. host disease (GVHD) and sinusoidal obstructive syndrome (SOS), are still largely unpredictable and remain the major causes of morbidity and mortality. Both donor and patient genetic background might influence the success of bone marrow transplantation and could at least partially explain the inter-individual variability in HSCT outcome. This review summarizes some of the recent studies on candidate gene polymorphisms in HSCT, with particular reference to pediatric cohorts. The interest is especially focused on pharmacogenetic variants affecting myeloablative and immunosuppressive drugs, although genetic traits involved in SOS susceptibility and transplant-related mortality are also reviewed.Keywords
This publication has 96 references indexed in Scilit:
- Transplant‐related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25‐year retrospective reviewPediatric Blood & Cancer, 2013
- Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive diseaseTherapeutic Advances in Hematology, 2012
- Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1)Atherosclerosis, 2011
- Regulation of cellular iron metabolismBiochemical Journal, 2011
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine DosingClinical Pharmacology & Therapeutics, 2011
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2010
- Chronic Graft-Versus-Host Disease (GVHD) in ChildrenPediatric Clinics of North America, 2010
- Transplantation immunology: Solid organ and bone marrowJournal of Allergy and Clinical Immunology, 2010
- The human hGSTA5 gene encodes an enzymatically active proteinBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: The multi-ethnic study of atherosclerosis (MESA)Atherosclerosis, 2008